Related Experiment Videos
[Lipid-metabolic and blood coagulation factors in chronic peripheral arteriopathies]
Insights
This study found that serum levels of HDL and LDL cholesterol, and Antithrombin III correlate with disease progression in patients with chronic obstructive arterial diseases, including those with diabetes.
Area of Science:
- Cardiovascular Medicine
- Clinical Chemistry
- Vascular Biology
Background:
- Chronic obstructive arterial diseases (COADs) encompass a range of vascular conditions affecting peripheral circulation.
- Lipid profiles and coagulation factors are crucial indicators in cardiovascular health and disease management.
Purpose of the Study:
- To investigate the correlation between specific serum biomarkers and disease progression in patients with COADs.
- To evaluate the utility of these biomarkers in monitoring peripheral vascular diseases, including in patients with diabetes mellitus.
Main Methods:
- Serum levels of cholesterol, triglycerides, HDL-cholesterol, and LDL-cholesterol were measured.
- Plasmatic levels of Antithrombin III, Quick time, PTT, fibrinogenaemia, and platelets were assessed.
- Patients with COADs at various stages, including those with diabetes, were included in the study.
Main Results:
- A significant correlation was observed between the levels of HDL-cholesterol, LDL-cholesterol, and Antithrombin III and the progression of COADs.
- The tested parameters showed varied behavior in relation to disease follow-up.
- Specific correlations were particularly notable for HDL and LDL cholesterol and Antithrombin III.
Conclusions:
- Serum HDL and LDL cholesterol, and Antithrombin III levels are valuable indicators for monitoring chronic obstructive arterial diseases.
- These biomarkers can aid in the clinical management and follow-up of patients with peripheral vascular diseases.
- The findings support the use of these biochemical tests for enhanced patient monitoring in vascular care.
Abstract:
The authors have tested serum levels of cholesterol, triglycerides, HDL-cholesterol and LDL-cholesterol, with the plasmatic levels of Antithrombin III and other parameters (Quick time, PTT, fibrinogenaemia and platelets) in patients affected by chronic obstructive arterious diseases in various stages including a group of patients affected by diabetes mellitus. The results show that there is a correlation between the behaviour of the parameter tested and the follow-up of the diseases, particularly for HDL and LDL cholesterol and Antithrombin III. The authors suggest the use of these tests for monitoring this kind of vascular peripheral diseases.